Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plant genomic DNA represents the complete set of genetic instructions required for the growth, development, and reproduction of plants, distributed across the nucleus, chloroplasts, and mitochondria (NCBI, 2023). It serves as the primary template for RNA synthesis and subsequent protein production, making it the master regulator of plant physiology and biochemistry. In biotechnology and agriculture, plant genomic DNA is the substrate for genetic modification and genome editing, aimed at enhancing crop resilience and nutritional content (Nature Reviews Genetics, 2019). While it is not a traditional therapeutic target for human diseases, it is frequently manipulated using chemical mutagens like ethyl methanesulfonate or biological tools like CRISPR-Cas9 to study gene function or develop new plant varieties. Understanding the complexity and organization of plant genomes is essential for addressing global challenges such as food security and climate change adaptation.
DNA alkylation, DNA intercalation, DNA strand cleavage, and site-specific gene editing.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plant Genomic DNA (gDNA).